Medasense Biometrics Ltd

Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication. Medasenses flagship product, PMD-200TM, is used in critical care settings, where patients are unable to communicate, to visualize pain response and personalize treatment. Clinical studies have demonstrated its impact on patient safety and outcomes including opioid sparing and lower pain scores reported by patients. PMD-200TM is distributed in Europe by Medtronic, and is also commercially available in Canada, Latin America, Israel, Australia and the United Arab Emirates. It enables...

Pain monitoring,nociception monitoring,analgesia monitoring,pain intelligence,general anesthesiology,patient monitoring,surgery,anesthesiology,artificial intelligence,pain control,patient safety,opioid sparing,sensors,sensor intelligence,and pain management

Medasense biometrics ltd operates in the Medical equipment manufacturing industry.

Medasense biometrics ltd's revenue is 11m - 100m

Medasense biometrics ltd has 11 - 50 employees.